4//SEC Filing
Gault Cheryl 4
Accession 0001839046-25-000004
CIK 0002012593other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:15 PM ET
Size
8.4 KB
Accession
0001839046-25-000004
Insider Transaction Report
Form 4
Gault Cheryl
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-09-08$38.33/sh−5,000$191,650→ 171,928 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-09-08−5,000→ 110,407 totalExercise: $1.80Exp: 2033-12-05→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-09-08$1.80/sh+5,000$9,000→ 176,928 total
Footnotes (2)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.
- [F2]25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0001839046
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:15 PM ET
- Size
- 8.4 KB